Lexeo Therapeutics
$5.72
4
+$0.05+0.88% Thursday 20:00
Statistics
Day High
5.83
Day Low
5.48
52W High
10.99
52W Low
1.45
Volume
611,887
Avg. Volume
1,001,291
Mkt Cap
417.49M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-0.351667
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-196.67MNet Income
Analyst Ratings
$20.17Average Price Target
The highest estimate is 30.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LXEO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York.
Show more...
CEO
Mr. R. Nolan Townsend
Employees
75
Country
US
ISIN
US52886X1072
Listings
0 Comments
Share your thoughts
FAQ
What is Lexeo Therapeutics stock price today?▼
The current price of LXEO is $5.72 USD — it has increased by +0.88% in the past 24 hours. Watch Lexeo Therapeutics stock price performance more closely on the chart.
What is Lexeo Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lexeo Therapeutics stocks are traded under the ticker LXEO.
Is Lexeo Therapeutics stock price growing?▼
LXEO stock has risen by +4.76% compared to the previous week, the month change is a -19.09% fall, over the last year Lexeo Therapeutics has showed a +116.67% increase.
What is Lexeo Therapeutics market cap?▼
Today Lexeo Therapeutics has the market capitalization of 417.49M
When is the next Lexeo Therapeutics earnings date?▼
Lexeo Therapeutics is going to release the next earnings report on May 07, 2026.
What were Lexeo Therapeutics earnings last quarter?▼
LXEO earnings for the last quarter are -0.33 USD per share, whereas the estimation was -0.52 USD resulting in a +36.54% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lexeo Therapeutics revenue for the last year?▼
Lexeo Therapeutics revenue for the last year amounts to 0 USD.
What is Lexeo Therapeutics net income for the last year?▼
LXEO net income for the last year is -196.67M USD.
How many employees does Lexeo Therapeutics have?▼
As of April 03, 2026, the company has 75 employees.
In which sector is Lexeo Therapeutics located?▼
Lexeo Therapeutics operates in the Health Care sector.
When did Lexeo Therapeutics complete a stock split?▼
Lexeo Therapeutics has not had any recent stock splits.
Where is Lexeo Therapeutics headquartered?▼
Lexeo Therapeutics is headquartered in New York, US.